FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.6% | -17.9% | -18.5% | -31.2% | +243.0% | -22.9% | +127.1% | -9.9% | -14.7% | -18.8% | +206.1% | |
| – | -18.6% | -17.8% | -18.4% | -31.3% | +247.2% | -23.1% | +128.2% | -11.3% | -15.5% | -19.2% | +211.9% | |
| – | -43.4% | -11.1% | +130.4% | -33.2% | +35.9% | +106.1% | +131.5% | -12.0% | -17.6% | -24.3% | -14.8% | |
| – | -19.6% | -18.0% | -19.5% | -33.2% | +256.7% | -21.4% | +131.5% | -12.0% | -17.6% | -24.3% | +240.9% | |
| – | – | – | – | – | – | – | – | – | +55.0% | -19.8% | – | |
| – | -50.9% | -9.1% | +173.6% | -5.9% | +5.8% | -0.5% | +1.5% | +41.7% | +67.7% | +15.3% | -12.6% | |
| – | -50.9% | -9.1% | +173.6% | -5.9% | +5.8% | -0.5% | +1.5% | +41.7% | +59.7% | +14.0% | -14.2% | |
| – | -73.4% | +18.3% | +213.1% | -2.2% | -5.4% | +3.0% | +5.5% | +3.6% | +81.9% | +31.0% | +7.1% | |
| – | -12.6% | -18.8% | -40.9% | -44.8% | +460.3% | -26.8% | +156.6% | -14.7% | -27.5% | -31.0% | +336.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,299.1% | -95.7% | +18.7% | +0.1% | +246.0% | +78.3% | +3.0% | +51.5% | +0.4% | -0.1% | +33.4% |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.